Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease

Nutrients. 2020 Nov 17;12(11):3531. doi: 10.3390/nu12113531.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is currently the most common form of liver disease in both adults and children, becoming the leading cause for liver transplant in many countries. Its prevalence has increased considerably in recent years, mainly due to the explosive increase in pediatric obesity rates. NAFLD is strongly associated with central obesity, diabetes, dyslipidemia and insulin resistance, and it has been considered as the hepatic manifestation of the metabolic syndrome. Its complex pathophysiology involves a series of metabolic, inflammatory and oxidative stress processes, among others. Given the sharp increase in the prevalence of NAFLD and the lack of an appropriate pharmacological approach, it is crucial to consider the prevention/management of the disease based on lifestyle modifications such as the adoption of a healthy nutrition pattern. Herein, we review the literature and discuss the role of three key nutrients involved in pediatric NAFLD: fructose and its participation in metabolism, Omega-3 fatty acids and its anti-inflammatory effects and vitamin E and its action on oxidative stress.

Keywords: NASH; fructose; nonalcoholic fatty liver disease (NAFLD); nutrition; omega 3 fatty acids; steatosis; sugar; vitamin E.

Publication types

  • Review

MeSH terms

  • Child
  • Fatty Acids, Omega-3 / pharmacology*
  • Fructose / adverse effects*
  • Fructose / metabolism
  • Humans
  • Life Style
  • Liver / drug effects*
  • Liver / metabolism
  • Liver / pathology
  • Non-alcoholic Fatty Liver Disease / drug therapy*
  • Non-alcoholic Fatty Liver Disease / etiology
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Oxidative Stress / drug effects
  • Randomized Controlled Trials as Topic
  • Vitamin E / pharmacology*

Substances

  • Fatty Acids, Omega-3
  • Vitamin E
  • Fructose